Hair loss drug shows promise in Long-Term trial for alopecia areata
Disease control
Ongoing
This study looks at the long-term safety and effectiveness of a drug called CTP-543 for adults with moderate to severe alopecia areata, a condition that causes patchy hair loss. About 1,000 people who already completed 24 weeks of treatment in a previous CTP-543 trial will contin…
Phase: PHASE2, PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC